Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with VRXA: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
VRXA
Veraxa Biotech AG - Post de-SPAC
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
VRXA
Veraxa Biotech AG - Post de-SPAC
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,418.70
· delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
VRXA
Veraxa Biotech AG - Post de-SPAC
Change
1.16
▲
+17.08%
· post 0.96
· delayed
After hours
Nov 4 '26
delayed
Mkt cap
$14.3M
Revenue
—
Revenue
—
vs
Compare
After hours
Nov 4 '26
delayed
LLY
ELI Lilly & Co
vs
VRXA
Veraxa Biotech AG - Post de-SPAC
1,417.89
▲
+0.60%
post 1,418.70
delayed
Price
1.16
▲
+17.08%
post 0.96
delayed
$1.3T
Mkt cap
$14.3M
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,417.89
▲
+0.60%
vs
VRXA
1.16
▲
+17.08%
After hours
Nov 4 '26
delayed
Co-movers
daily closes
Method
›
Moved together
LLY
with
VRXA
No shared trading history for LLY and VRXA.
Shared co-movers: not yet measured (VRXA).
LLY, solid
VRXA, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes